ECCO Tour Hybrid Adds Sophistication to Golf's Fastest-Growing Footwear Category

By: Golf Shake | Fri 11 Jan 2013 | Comments


5092-eccoECCO have announced the launch of its men’s Tour Hybrid model, the first-ever crossover model featuring a classic leather upper design atop the company’s award-winning Street outsole.

By combining hand-crafted elegance with advanced shoemaking technologies, ECCO has created a style which uniquely and seamlessly transitions from the boardroom to the car to the country club.

Suitable for business and casual settings, Tour Hybrid boasts a patented outsole configuration of approximately 100 moulded traction bars and 800-plus traction angles. Constructed from TPU – a highly durable, wear-resistant material – these elements provide superior grip in all conditions.

5092-ecco“It’s in our DNA to pioneer comfort, performance and style trends,” says Michael Waack, Head of Global Golf at ECCO. “With each collection, we want to excite the trade and consumer markets while leaving them wondering what will be our next innovation.”

Additional features of the refined new Tour Hybrid include:

  • Three distinct upper patterns and several color options to suit a variety of looks
  • 100 percent waterproof GORE-TEX® and supremely weather resistant Hydromax™ leathers
  • Lining made from Second Skin – the world’s softest leather – which wicks moisture and creates a rich interior feel
  • Removable ECCO Comfort Fibre System insole increases air circulation and creates a fresh, cool shoe climate

5092-eccoTour Hybrid will start to become available through early 2013.

This and other styles from the 2013 ECCO men’s golf collection will be worn in competition by Fred Couples, Graeme McDowell, Thomas Bjorn, Thongchai Jaidee, Stuart Appleby, Bradley Dredge, Andreas Hartø and scores of other Tour stars worldwide.

For further inspiration visit www.ecco.com/golf.   

 

 


What do you think? leave your comments below (Comments)


Tags: ecco


Advertisement




Leave your comments below

comments powered by Disqus

Prostate Cancer UK

Scroll to top